Publications by authors named "Ariane Klein"

Claim this Profile
I
Infant-onset juvenile idiopathic arthritis - a multicenter retrospective study.
Timmy Strauss, Jens Klotsche, Daniel Windschall, Anthony Sprengel, Manuela Krumrey-Langkammerer, Ariane Klein

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort.
Florian Milatz, Malthe Jessen Pedersen, Jens Klotsche, Ina Liedmann, Martina Niewerth, Ariane Klein

Pediatr Rheumatol Online J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Course of the COVID-19 pandemic in pediatric rheumatological patients in Germany during the first 3 years (2020-2022)].
Ariane Klein, Hans-Iko Huppertz, Gerd Horneff

Z Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registry.
Angela Zimmer, Ariane Klein, Jasmin B Kuemmerle-Deschner, Frank Dressler, Nils Onken

Rheumatol Int· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis.
Johanna Roemer, Ariane Klein, Gerd Horneff

Rheumatol Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival.
Franz Thiele, Ariane Klein, Jens Klotsche, Daniel Windschall, Frank Dressler

Rheumatology (Oxford)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Ilse J Broekaert, Ariane Klein, Daniel Windschall, Betina Rogalski, Frank Weller-Heinemann

J Pediatr Gastroenterol Nutr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care.
Prasad T Oommen, Timmy Strauss, Karen Baltruschat, Ivan Foeldvari, Christoph Deuter, Ariane Klein

Clin Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of adult patients with JIA treated with the biosimilar Benepali: results of the biologic register JuMBO.
Kristina Vollbach, Klaus Tenbrock, Nobert Wagner, Gerd Horneff, Ariane Klein

Arthritis Res Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study.
Laura J Montag, Gerd Horneff, Paula Hoff, Ariane Klein, Tilmann Kallinich

RMD Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial.
Joachim Gerss, Monika Tedy, Ariane Klein, Gerd Horneff, Maria Miranda-Garcia

Ann Rheum Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries.
Lianne Kearsley-Fleet, Jens Klotsche, Joeri W van Straalen, Wendy Costello, Gianfranco D'Angelo, Ariane Klein

Rheumatology (Oxford)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study.
Franz Thiele, Ariane Klein, Anton Hospach, Daniel Windschall, Sonja Mrusek

ACR Open Rheumatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.
Claudia Sengler, Sascha Eulert, Kirsten Minden, Martina Niewerth, Gerd Horneff, Ariane Klein

RMD Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry.
Franz Thiele, Ariane Klein, Daniel Windschall, Anton Hospach, Ivan Foeldvari

Rheumatol Int· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis.
Jens Klotsche, Ariane Klein, Martina Niewerth, Paula Hoff, Daniel Windschall

Arthritis Res Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The German National Registry of Primary Immunodeficiencies (2012-2017).
Sabine M El-Helou, Anika-Kerstin Biegner, Sebastian Bode, Stephan R Ehl, Maximilian Heeg, Christoph Klein, Ariane Klein

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry.
Giulia Armaroli, Ariane Klein, Gerd Ganser, Michael J Ruehlmann, Frank Dressler

Arthritis Res Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry.
Ariane Klein, Jens Klotsche, Boris Hügle, Kirsten Minden, Anton Hospach

Rheumatology (Oxford)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis.
Ariane Klein, Kirsten Minden, Anton Hospach, Ivan Foeldvari, Frank Weller-Heinemann

Ann Rheum Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER Registry.
Ariane Klein, Ingrid Becker, Kirsten Minden, Anton Hospach, Tobias Schwarz

ACR Open Rheumatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Biologics in the treatment of juvenile idiopathic arthritis : A comparison of mono- and combination therapy with synthetic DMARDs].
Ariane Klein

Z Rheumatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young Adulthood.
Kirsten Minden, Gerd Horneff, Martina Niewerth, Eva Seipelt, Martin Aringer, Ariane Klein

Arthritis Care Res (Hoboken)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries.
Joost Swart, Gabriella Giancane, Gerd Horneff, Bo Magnusson, Michael Hofer, Ariane Klein

Arthritis Res Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON).
Miriam Listing, Kirsten Mönkemöller, Ina Liedmann, Martina Niewerth, Claudia Sengler, Ariane Klein

Arthritis Res Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis